Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

✍ Scribed by B. Eliasson; D. Möller-Goede; K. Eeg-Olofsson; C. Wilson; J. Cederholm; P. Fleck; M. Diamant; M.-R. Taskinen; U. Smith

• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 311 KB
• Volume: 55
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-011-2447-3